Proglicem 25 mg Capsules
PDF Leaflet Revision Date: 28 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Management of intractable hypoglycaemia.
Dosage (summary)
Adults: 3-8 mg/kg divided into 2-3 doses every 8-12 hours; starting at 3 mg/kg/day.
Special Populations
- Infants
- Newborns
Pregnancy & Breastfeeding
Safety and efficacy not established.
Key Drug Interactions
- Warfarin
- Diphenylhydantoin
- Thiazides
Contraindications
- Functional hypoglycaemia
- Hypersensitivity to diazoxide
Common side effects
- Hyperglycaemia
- Fluid retention
- Dizziness
- Nausea
Counselling Points
- Monitor for signs of fluid retention
- Regular blood tests recommended
Serious warnings
- Monitor blood glucose and blood counts
- Risk of ketoacidosis
Important Disclaimer
The Proglicem 25 mg Capsules professional information leaflet below is the property of Msd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
